Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …

Importance Therapies that improve survival in critically ill patients with coronavirus disease
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …

Rationale & Objective Underlying kidney disease is an emerging risk factor for more severe
coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically …

Purpose Limited data are available on venovenous extracorporeal membrane oxygenation (ECMO)
in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 (…

Objectives To estimate the incidence, risk factors, and outcomes associated with in-hospital
cardiac arrest and cardiopulmonary resuscitation in critically ill adults with coronavirus …

Background: Hypercoagulability may be a key mechanism of death in patients with
coronavirus disease 2019 (COVID-19). Objective: To evaluate the incidence of venous …

… We used the model’s predicted probabilities to calculate stabilized IP weights ( 23 ), which
we then applied to weight each individual’s contribution to the survival curves and to the Cox …

… We also recognize that patient goals of care are often revisited during the patient’s hospital
course; … Furthermore, this study reflects a single institution’s ICU admission decision-making …

… Correspondence and requests for reprints should be addressed to Kusum S. Mathews, MD,
MPH, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New …

Pulmonary embolus (PE) is estimated to cause 200 000 to 300 000 deaths annually. Many
deaths occur in hemodynamically unstable patients and the estimated mortality for inpatients …